رجوع
نطاق اليوم
KWD 77.00
KWD 78.64
نطاق 52 أسبوعًا
KWD 35.61
KWD 94.15
حجم التداول
1,818
متوسط 50 يوم / 200 يوم
KWD 81.21
/
KWD 66.97
الإغلاق السابق
KWD 75.94
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 46.0 | 0.2 |
| P/B | 3.6 | 3.0 |
| ROE % | 8.3 | 3.6 |
| Net Margin % | 8.2 | 3.8 |
| Rev Growth 5Y % | 0.1 | 9.9 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 3.74
KWD 3.68 – KWD 3.80
|
9.38B | 1 |
| FY2026 |
KWD 3.36
KWD 3.30 – KWD 3.41
|
8.99B | 1 |
No quarterly estimates available
Earnings Surprises
Last 2 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | KWD 1.23 | — |
| 2025-08-07 | N/A | KWD 0.86 | — |
Dividend History
2 yr streakYield
0.01%
Payout Ratio
0.43%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 22, 2025 | Jun 03, 2025 | KWD 0.73 | 1.83% |
| May 03, 2024 | Jun 18, 2024 | KWD 0.50 | 1.45% |
النقاط الرئيسية
Revenue grew 0.12% annually over 5 years — modest growth
Earnings grew 72765.14% over the past year
Generating 810.00M in free cash flow
P/E of 45.96 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.01%
Cash machine — converts 111.16% of earnings into free cash flow
النمو
Revenue Growth (5Y)
0.12%
Revenue (1Y)-14.89%
Earnings (1Y)72765.14%
FCF Growth (3Y)N/A
الجودة
Return on Equity
8.31%
ROIC6.77%
Net Margin8.24%
Op. Margin15.38%
الأمان
Debt / Equity
0.61
Current Ratio1.18
Interest Coverage7.75
التقييم
P/E Ratio
45.96
Forward P/E22.61
P/B Ratio3.57
EV/EBITDA27.54
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -14.89% | Revenue Growth (3Y) | -5.89% |
| Earnings Growth (1Y) | 72765.14% | Earnings Growth (3Y) | 207.62% |
| Revenue Growth (5Y) | 0.12% | Earnings Growth (5Y) | -3.21% |
| Profitability | |||
| Revenue (TTM) | 8.84B | Net Income (TTM) | 728.65M |
| ROE | 8.31% | ROA | 3.31% |
| Gross Margin | 47.02% | Operating Margin | 15.38% |
| Net Margin | 8.24% | Free Cash Flow (TTM) | 810.00M |
| ROIC | 6.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.61 | Current Ratio | 1.18 |
| Interest Coverage | 7.75 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.43% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 2 yrs | ||
| Valuation | |||
| P/E Ratio | 45.96 | Forward P/E | 22.61 |
| P/B Ratio | 3.57 | P/S Ratio | 3.79 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 27.54 | Fwd EV/EBITDA | 30.65 |
| Forward P/S | 3.72 | Fwd Earnings Yield | 4.42% |
| FCF Yield | 2.42% | ||
| Market Cap | 33.49B | Enterprise Value | 37.43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.84B | 10.38B | 9.98B | 8.60B | 8.79B |
| Net Income | 728.65M | 1.00M | 77.00M | 784.05M | 830.15M |
| EPS (Diluted) | 1.67 | 0.00 | 0.18 | 1.82 | 1.93 |
| Gross Profit | 4.16B | 4.93B | 4.56B | 4.05B | 4.15B |
| Operating Income | 1.36B | 307.00M | 375.00M | 1.15B | 1.38B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 22.03B | 19.91B | 19.43B | 16.23B | 15.98B |
| Total Liabilities | 12.65B | 11.74B | 10.78B | 22,861.0 | 8.55B |
| Shareholders' Equity | 9.38B | 8.16B | 8.65B | 77,139.0 | 7.43B |
| Total Debt | 5.68B | 4.85B | 4.55B | 3.87B | 4.51B |
| Cash & Equivalents | 1.74B | 1.19B | 1.11B | 74.00M | 36.45M |
| Current Assets | 8.17B | 7.80B | 7.57B | 100,000.0 | 5.07B |
| Current Liabilities | 6.90B | 6.31B | 5.70B | 22,861.0 | 7.62B |